<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We examined a clinical database for patients receiving financial aid for treatment to elucidate age at <z:hpo ids='HP_0003674'>onset</z:hpo> of intractable disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Data were obtained from the clinical database of patients receiving financial aid for treatment in 2003 </plain></SENT>
<SENT sid="2" pm="."><plain>Age at <z:hpo ids='HP_0003674'>onset</z:hpo> of disease was calculated by subtracting the year of birth from the year of <z:hpo ids='HP_0003674'>onset</z:hpo> as registered in the database </plain></SENT>
<SENT sid="3" pm="."><plain>Percentiles for age at <z:hpo ids='HP_0003674'>onset</z:hpo> and peak <z:hpo ids='HP_0003674'>onset</z:hpo> age were evaluated for each intractable disease </plain></SENT>
<SENT sid="4" pm="."><plain>Peak <z:hpo ids='HP_0003674'>onset</z:hpo> ages for primary <z:hpo ids='HP_0002721'>immune-deficiency</z:hpo> syndrome, <z:hpo ids='HP_0011011'>subacute</z:hpo> sclerosing <z:e sem="disease" ids="C1112174" disease_type="Disease or Syndrome" abbrv="">panencephalitis</z:e>, lysosomal diseases, <z:e sem="disease" ids="C0014527" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">epidermolysis bullosa</z:e> and <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> I and II were under 20 years </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Peak <z:hpo ids='HP_0003674'>onset</z:hpo> ages for <z:mp ids='MP_0010139'>aortitis</z:mp> syndrome, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's disease</z:e>, <z:e sem="disease" ids="C0162309" disease_type="Disease or Syndrome" abbrv="ALD">adrenoleukodystrophy</z:e>, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> were between 20 and 50 </plain></SENT>
<SENT sid="6" pm="."><plain>Distributions of age at <z:hpo ids='HP_0003674'>onset</z:hpo> for <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0001973'>idiopathic thrombocytopenic purpura</z:hpo>, <z:hpo ids='HP_0003473'>myasthenia</z:hpo> gravis, <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">moyamoya disease</z:e> and <z:e sem="disease" ids="C0036202" disease_type="Disease or Syndrome" abbrv="">sarcoidosis</z:e> were bimodal </plain></SENT>
<SENT sid="7" pm="."><plain>Peak <z:hpo ids='HP_0003674'>onset</z:hpo> age for many other diseases were &gt; or = 40 years </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Using a clinical database for patients receiving financial aid for treatment, the distribution of ages at <z:hpo ids='HP_0003674'>onset</z:hpo> and peak <z:hpo ids='HP_0003674'>onset</z:hpo> ages could be systematically clarified for individual intractable diseases </plain></SENT>
<SENT sid="9" pm="."><plain>Our study provides new information on the natural history of disease development </plain></SENT>
</text></document>